Last update:

Oncology & Cancer news

Oncology & Cancer

Study shows mechanical stiffness of tissue can alter fate of tumor cell populations

Ongoing fundamental research on cancer cells could be used to create new drugs and therapies that fight the spread of cancer cells. The work of Dr. Tanmay Lele, joint faculty in chemical engineering, and chemical engineering ...

Oncology & Cancer

Cell therapy fights lethal childhood brain cancer in clinical trial

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford Medicine clinical trial—erased all detectable traces of a brain cancer typically considered incurable.

Oncology & Cancer

Detecting pancreatic cancer

November is National Pancreatic Cancer Awareness Month. Approximately 66,000 people in the U.S. will be diagnosed with pancreatic cancer this year, according to the National Cancer Institute.

Oncology & Cancer

'Moonlighting' enzymes may lead to new cancer therapies

Researchers at the Center for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected "second jobs" within the nucleus, orchestrating ...

Oncology & Cancer

Medicaid enrollment continuity tied to lymphoma stage at diagnosis

Continuous enrollment in Medicaid was associated with a lower rate of a late-stage lymphoma diagnosis in children and adolescents/young adults (AYAs). However, fewer than half of Medicaid-insured patients in these age ranges ...

Medications

FDA approves Itovebi for locally advanced, metastatic breast cancer

The U.S. Food and Drug Administration has approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, ...

Oncology & Cancer

Breast cancer drug shows potential for rare appendix cancer

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an effective therapeutic for a specific type of appendix cancer.

Oncology & Cancer

New AI tool could enhance and personalize brain tumor imaging

A new artificial intelligence (AI) tool developed by researchers at UCL and UCLH can analyze scans more quickly than experienced neuroradiologists and provide greater patient-personalized detail to aid treatment.

Oncology & Cancer

Researchers show tumor evolution is written in the genome

Using a system of genetic barcodes and a novel single-cell sequencing method, a research team at the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) in Milan has developed an approach to identify cells ...

Oncology & Cancer

Extrachromosomal DNA could be a target of future cancer therapies

Research published in Nature Genetics on Oct.14, by Yale Cancer Center researchers at Yale School of Medicine, found a higher concentration of a specific kind of DNA—extrachromosomal or ecDNA—in more aggressive and advanced ...

Oncology & Cancer

Immune signatures may predict adverse events from immunotherapy

Distinct immune "signatures" in patients who develop adverse events while receiving immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a ...

Oncology & Cancer

The importance of breast cancer screening

October is Breast Cancer Awareness Month. Breast cancer is the second-leading cause of cancer deaths in women across the U.S. And rates of the disease continue to climb, notably among younger women. A report from the American ...

Oncology & Cancer

Promising treatment for gastrointestinal stromal tumors

About 1,200 Germans are diagnosed with gastrointestinal stromal tumors every year—a rare type of cancer in which the tumors develop in the walls of the digestive organs and quickly develop resistance to common precision ...

Oncology & Cancer

Clinical trials confirm zolbetuximab's efficacy in gastric cancer

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of tumor-related deaths. This is due to late diagnosis and the rapid spread of tumor cells throughout ...